CollPlant Biotechnologies (CLGN) Enterprise Value (QoQ) (2018 - 2026)
CollPlant Biotechnologies (CLGN) Enterprise Value (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.10% |
| Dec 31, 2025 | 50.04% |
| Sep 30, 2025 | -1.73% |
| Jun 30, 2025 | 95.44% |
| Mar 31, 2025 | 1.15% |
| Dec 31, 2024 | 2.90% |
| Sep 30, 2024 | -1,297.34% |
| Jun 30, 2024 | 92.79% |
| Mar 31, 2024 | -782.49% |
| Dec 31, 2023 | 88.19% |
| Sep 30, 2023 | -1,040.04% |
| Jun 30, 2023 | 16.45% |
| Mar 31, 2023 | 86.71% |
| Dec 31, 2022 | -510.22% |
| Sep 30, 2022 | 9.54% |
| Jun 30, 2022 | 11.63% |
| Mar 31, 2022 | 99.98% |
| Dec 31, 2021 | -820,443.71% |
| Sep 30, 2021 | -46.97% |
| Jun 30, 2021 | 90.88% |